Company Number: 14402763

Analysis Date: 2025-07-20 14:07 UTC

Financial Health Assessment for FLOW PRODUCTS LTD

---

1. Financial Health Score: B

Explanation:
FLOW PRODUCTS LTD exhibits a solid and improving financial profile, especially given its recent incorporation in late 2022. The company has moved from a net liability position in 2021 to a strong net asset position by the end of 2023. The upward trend in net current assets and shareholders' funds indicates healthy growth and better liquidity management. The score B reflects good financial health but with room to strengthen, particularly as a micro-entity still in early development.

---

2. Key Vital Signs: Critical Metrics and Interpretation

Metric	2021	2022	2023	Interpretation
Fixed Assets	£818	£853	£4,323	Gradual increase, indicating investment in long-term assets—positive sign of business expansion.
Current Assets	£3,945	£2,157	£24,805	Significant jump in 2023, showing improved liquidity and cash reserves—a healthy cash flow symptom.
Current Liabilities	£5,079	£5,000	£7,838	Slight increase, but manageable given the rise in current assets.
Net Current Assets	-£1,134	£2,157	£17,775	From negative working capital in 2021 to strong positive in 2023, reflecting improved short-term financial health and ability to meet obligations.
Net Assets	-£791	£1,990	£21,063	Shift from negative to strong net assets demonstrates overall strengthening of company equity and balance sheet health.
Shareholders Funds	-£791	£1,990	£21,063	Mirrors net assets, confirming equity growth and retained earnings accumulation.

Additional Observations:

• Average employees increased from 1 in 2022 to 2 in 2023, indicating modest business growth.
• No overdue filings or compliance issues detected, suggesting good governance and operational stability.
• Sole PSC (Mr. James Michael Phelan) holds 75-100% control, which implies centralized decision-making.

---

3. Diagnosis: What the Financial Data Reveals About Business Health

FLOW PRODUCTS LTD is displaying classic signs of an early-stage company transitioning from start-up losses or low equity into a more stable and solvent position:

• Healthy Cash Flow: The large increase in current assets in 2023 suggests the company is generating or holding more cash or receivables, providing liquidity to cover short-term liabilities comfortably.
• Improved Working Capital: The positive net current assets indicate the company can meet its short-term debts without distress—no symptoms of liquidity crunch.
• Asset Growth: Increased fixed assets reflect investment in operational capabilities or equipment, indicating confidence in future revenue generation.
• Capital Stability: Shareholders' funds have risen substantially, implying reinvested profits or new equity injections, improving the financial buffer against losses.
• Micro-Entity Status: The company remains small, with low employee count and micro accounting category, which means limited complexity but also limited scale.

No red flags such as negative net assets, overdue filings, or signs of distress exist. The company is in a healthy growth phase, with improving financial fundamentals.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

1. Maintain Strong Cash Flow Management:
   Continue monitoring receivables and payables to ensure operating cash remains strong, preventing liquidity shocks as the business scales.

2. Plan for Scaling Operations:
   With growing fixed assets and employees, consider budgeting for operational efficiencies and potential financing needs to support further growth without overextending liabilities.

3. Strengthen Equity Base:
   If possible, inject additional equity or retain earnings to buffer against future risks, ensuring the company stays solvent during market fluctuations.

4. Keep Compliance on Track:
   Ensure timely filing of accounts and confirmation statements to avoid penalties and maintain good corporate standing.

5. Diversify Customer or Supplier Base:
   To avoid overreliance on limited parties, broadening business relationships can reduce risks associated with single-source dependencies.

6. Implement Financial Forecasting:
   Use budgets and cash flow forecasts to anticipate future capital needs and operational expenses, enabling proactive management.

---

Medical Analogy Summary

FLOW PRODUCTS LTD shows a strong pulse with a healthy cash flow and resilient working capital. The company has recovered from early "financial illnesses" (negative net assets) and is now showing the symptoms of robust growth and financial wellness. Continued vigilance and strategic investment will be key to sustaining this upward trajectory and preventing any future "financial distress."

---